Schonfeld Strategic Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-2,490	Closed	-$260K	–	2201
2025 Q2	$260K	Sell	2,490 -21,710	-90%	-$2.3M	﹤0.01%	1729
2025 Q1	$2.82M	Sell	24,200 -1,180	-5%	-$134K	0.02%	784
2024 Q4	$2.15M	Sell	25,380 -56,617	-69%	-$5.21M	0.01%	802
2024 Q3	$7.37M	Buy	81,997 +23,088	+39%	+$2.02M	0.06%	393
2024 Q2	$4.74M	Sell	58,909 -1,273	-2%	-$94.3K	0.04%	570
2024 Q1	$4.8M	Sell	60,182 -46,660	-44%	-$3.92M	0.04%	668
2023 Q4	$8.5M	Buy	106,842 +39,144	+58%	+$2.62M	0.07%	397
2023 Q3	$4.73M	Sell	67,698 -7,614	-10%	-$569K	0.04%	563
2023 Q2	$5.41M	Buy	75,312 +64,999	+630%	+$4.79M	0.05%	463
2023 Q1	$636K	Sell	10,313 -74,042	-88%	-$4.86M	0.01%	1106
2022 Q4	$6.51M	Buy	84,355 +34,955	+71%	+$2.09M	0.05%	408
2022 Q3	$2.2M	Sell	49,400 -224	-0.5%	-$11.2K	0.02%	824
2022 Q2	$1.9M	Buy	49,624 +42,324	+580%	+$1.34M	0.02%	761
2022 Q1	$302K	Buy	+7,300	New	+$226K	﹤0.01%	1691
2021 Q4	–	Sell	-1,317	Closed	-$44K	–	2141
2021 Q3	$44K	Buy	+1,317	New	+$51.3K	﹤0.01%	2006
2020 Q3	–	Sell	-19,886	Closed	-$1.64M	–	1366
2020 Q2	$1.64M	Buy	19,886 +7,267	+58%	+$559K	0.05%	464
2020 Q1	$742K	Sell	12,619 -17,569	-58%	-$1.43M	0.05%	464
2019 Q4	$3.12M	Sell	30,188 -92,312	-75%	-$3.73M	0.08%	272
2019 Q3	$2.48M	Sell	122,500 -487,300	-80%	-$12.5M	0.07%	273
2019 Q2	$15.7M	Buy	609,800 +485,300	+390%	+$9.73M	0.56%	39
2019 Q1	$1.77M	Buy	+124,500	New	+$1.16M	0.06%	375